Studies on the signal transduction of difrentiation inducing factor and an application for the development of anti-cancer drug for early G_1 phase.
Studies on the signal transduction of difrentiation inducing factor and an application for the development of anti-cancer drug for early G_1 phase.
批准号:
14370034
负责人:
SASAGURI Toshiyuki
金额:
$6.72万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Differentiation-inducing factors (DIFs) are morphogens which induce cell differentiation in Dictyostelium. However, the effect of the DIF family is not limited in Dictyostelium. DIF-1 and/or DIF-3 strongly inhibit cell proliferation and induce cell differentiation in several mammalian cells. We therefore investigated the mechanisms for the antiproliferative action of DIFs in mammalian cells.We found that DIFs (DIF-1 and DIF-3) activates GSK-3β to accelerate the proteolysis of cyclin D1 and this mechanism is involved in the DIFs-induced G_0/G_1 arrest in mammalian cells. We next examined the effect of DIFs on cyclin D1 mutants and found that the phosphorylation of Thr^<286> was critical for cyclin D1 degradation induced by DIFs. These findings suggest that DIF-1 induces degradation of cyclin D1 through the GSK-3β-mediated phosphorylation of Thr^<286>. Moreover, we tried to identify the mechanism for the DIF-1-induced suppression of cyclin D1 mRNA expression and found that DIF-1 induces GSK-3β-mediaged degradation of β-catenin, resulting in the suppression of TCF/LEF transcriptional activity in the cyclin D1 promoter.Further, we tried to identify a kinase which induce phosphorylation on Tyr^<216> in GSK-3β and suggested that MEK1/2 induces tyrosine phosphorylation of GSK-3β and this cellular event might induce nuclear translocation of GSK-3β.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1074/jbc.m205768200
发表时间:
2003-03-14
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Takahashi-Yanaga, F, Taba, Y, Sasaguri, T]
通讯作者:
Sasaguri, T
Fumi Takahashi-Yanaga et al.: "Glycogen synthase kinase-3b is tyrosine phosphorylated by MEK1 in human skin fibroblasts"Biochem.Biophys.Res.Commun.. In press. (2004)
Fumi Takahashi-Yanaga 等人:“糖原合成酶激酶 3b 在人皮肤成纤维细胞中被 MEK1 酪氨酸磷酸化”Biochem.Biophys.Res.Commun.. 正在出版。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fumi Takahashi-Yanaga et al.: "Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells"J.Biol.Chem.. 278. 9663-9670 (2003)
Fumi Takahashi-Yanaga 等人:“盘基网柄菌分化诱导因子 3 激活糖原合酶激酶 3β 并降解哺乳动物细胞中的细胞周期蛋白 D1”J.Biol.Chem.. 278. 9663-9670 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fumi Takahashi-Yanaga et al.: "Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells"J. Biol. Chem.. (in press). (2003)
Fumi Takahashi-Yanaga 等人:“盘基网柄菌分化诱导因子 3 激活糖原合成酶激酶 3β 并降解哺乳动物细胞中的细胞周期蛋白 D1”J. Biol.(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Identification of an inhibitor of mPGES-1 expression and its target molecule
-
批准号:23659138
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:SASAGURI Toshiyuki
-
依托单位:
Pharmacogenetic studies on the influence of ALDH2 gene polymorphisms on the vasodilation induced by organic nitrates
-
批准号:20390160
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.98万
-
财政年份:2008
-
负责人:SASAGURI Toshiyuki
-
依托单位:
Linkage between G protein-coupled receptors and the Jak/STAT pathway in cardiovascular cells
-
批准号:10670695
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.83万
-
财政年份:1998
-
负责人:SASAGURI Toshiyuki
-
依托单位:
Regulation of proliferatin in vascular endothelial and smooth muscle cells by the protein kinase C pathway
-
批准号:07833014
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1995
-
负责人:SASAGURI Toshiyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
-
批准号:82371223
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:闻大翔
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
-
批准号:82372089
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李万万
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
-
批准号:82372724
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:何竑超
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
EGFR通过激活β-catenin重塑肿瘤微环境代谢调控肿瘤免疫逃逸的分子机制研究
-
批准号:32100574
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邵飞
-
依托单位:
脯氨酸羟化酶EglN1转位到线粒体介导乳腺癌细胞适应缺氧应激的机制研究
-
批准号:32100570
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:闫朝君
-
依托单位: